API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin

Model NO.
Dsung-Roxithromycin
CAS No.
80214-83-1
Molecular Formula
C41h76n2o15
Shelf Life
2 Years
Test Method
HPLC
Boiling Point
864.7 C at 760 Mmhg
Density
1.25g/cm3
Melting Point
115- 120 C
MW
837.04700
Assay
HPLC 99%
Grade
Pharmaceutical Grade
Specific
COA
Application
Antibiotics
Name
Roxithromycin Powder
Appearance
White Powder
Product Name
Roxithromycin
Transport Package
Negotiable
Specification
99%
Trademark
D-Sung
Origin
Shaanxi
Production Capacity
500kg/Month
Reference Price
$ 36.00 - 108.00

Product Description

API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin
API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin
 
Product Description

API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin

Product Details

API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin

Product Name Roxithromycin
CAS No. 80214-83-1
Purity 99%
MW 837.04700
Appearance and shape White powder
Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin is derived from erythromycin, containing the same 14-membered lactone ring. However, an N-oxime side chain is attached to the lactone ring. It is also currently undergoing clinical trials for the treatment of male-pattern hair loss.
Application & Function

API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin is derived from erythromycin, containing the same 14-membered lactone ring. However, an N-oxime side chain is attached to the lactone ring. It is also currently undergoing clinical trials for the treatment of male-pattern hair loss.
1.Macrolide antibiotics, erythromycin derivatives, antibacterial spectrum and erythromycin similar, but the role of 6 times stronger than erythromycin, bioavailability. For respiratory infections such as pneumonia, acute bronchitis, acute exacerbation of chronic bronchitis, atypical pneumonia, and genitourinary infections, skin and soft tissue infections, have good therapeutic effect and tolerance, adverse reactions than erythromycin Small.
2. This product is a new generation of macrolide antibiotics, mainly for Gram-positive bacteria, anaerobic bacteria, chlamydia and mycoplasma. Its antibacterial activity in vitro and erythromycin similar to the role of the body stronger than erythromycin 1-4 times.
3. In clinical medicine for drug-resistant Staphylococcus aureus and hemolytic streptococcus caused by the preferred drug, veterinary clinical treatment of penicillin-resistant, Staphylococcus aureus caused by severe infections, pneumonia, metritis, chronic respiratory disease of fowls Wait.
4. Mainly used for the treatment of chronic respiratory disease in livestock and poultry, Staphylococcus aureus and streptococcal disease, chlamydia, spirochaetosis (swine dysentery), infectious pleurisy, rhinitis and so on.

Specification

API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin API Roxithromycin Medicine Material Roxithromycin Tablet Powder Roxithromycin

 

 

CAFE24.COM, 2023